Revolution Medicines is a clinical-stage oncology company developing RAS(ON) tri-complex inhibitors targeting RAS-addicted cancers through an integrated portfolio of oral inhibitors. This Senior Scientist II role is within the company's Analytical Development team, based in Redwood City, California.
Text as published by the employer. Always confirm details on the employer's site.